Brandon Folkes
Stock Analyst at H.C. Wainwright
(2.07)
# 3,818
Out of 4,531 analysts
486
Total ratings
42.6%
Success rate
0.3%
Average return
Main Sectors:
Stocks Rated by Brandon Folkes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $11 | $0.6973 | +1,477.51% | 10 | Jul 16, 2026 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Reiterated: Buy | $12.62 | $1.69 | +646.92% | 13 | Jul 14, 2026 | |
| ANIP ANI Pharmaceuticals | Maintained: Buy | $121 | $79.20 | +52.78% | 22 | Jul 13, 2026 | |
| OMER Omeros | Reiterated: Buy | $40 → $33 | $9.69 | +240.56% | 23 | Jun 29, 2026 | |
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $7 | $2.38 | +194.12% | 15 | Jun 25, 2026 | |
| ACHV Achieve Life Sciences | Reiterated: Buy | $12 | $6.27 | +91.39% | 13 | Jun 23, 2026 | |
| ENTA Enanta Pharmaceuticals | Reiterated: Buy | $20 | $13.74 | +45.56% | 11 | Jun 23, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $26 | $12.77 | +103.60% | 12 | Jun 23, 2026 | |
| TRAW Traws Pharma | Downgraded: Hold | $8 → $1 | $0.671 | +49.03% | 4 | Jun 18, 2026 | |
| HRTX Heron Therapeutics | Maintained: Buy | $2 | $0.4707 | +324.90% | 38 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 → $3 | $1.33 | +126.42% | 19 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.03 | +148.14% | 22 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $0.8621 | +827.97% | 7 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.19 | +575.11% | 14 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $5.00 | +260.00% | 8 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $7.82 | +270.84% | 8 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.59 | +528.93% | 2 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $8.42 | +54.39% | 12 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $26.99 | +122.30% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.37 | +142.09% | 9 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15.43 | $9.27 | +66.43% | 15 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $7.16 | +81.56% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $36.08 | +66.30% | 40 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $8.80 | +13.64% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $19.07 | +10.12% | 12 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $40.54 | +18.40% | 6 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $200 | $2.80 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $6.13 | n/a | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $16 | $7.63 | n/a | 29 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $4 | $3.13 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $10 | $0.95 | n/a | 2 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 2 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 → $33 | $0.595 | n/a | 18 | Mar 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $15 | $2.38 | n/a | 15 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $271.82 | n/a | 1 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $40 | $0.705 | n/a | 2 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.001 | n/a | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $50 | $0.0111 | n/a | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $32 | $52.72 | n/a | 12 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $25 | $39.85 | n/a | 3 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $247.53 | n/a | 10 | Oct 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $8 | $0.000001 | n/a | 4 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $25.00 | n/a | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $12 | $9.60 | n/a | 9 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $33 | $17.38 | n/a | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $30 | $33.31 | n/a | 2 | Sep 12, 2016 |
Rani Therapeutics Holdings
Jul 16, 2026
Reiterated: Buy
Price Target: $11
Current: $0.6973
Upside: +1,477.51%
Cardiol Therapeutics Inc.
Jul 14, 2026
Reiterated: Buy
Price Target: $12.62
Current: $1.69
Upside: +646.92%
ANI Pharmaceuticals
Jul 13, 2026
Maintained: Buy
Price Target: $121
Current: $79.20
Upside: +52.78%
Omeros
Jun 29, 2026
Reiterated: Buy
Price Target: $40 → $33
Current: $9.69
Upside: +240.56%
Connect Biopharma Holdings
Jun 25, 2026
Reiterated: Buy
Price Target: $7
Current: $2.38
Upside: +194.12%
Achieve Life Sciences
Jun 23, 2026
Reiterated: Buy
Price Target: $12
Current: $6.27
Upside: +91.39%
Enanta Pharmaceuticals
Jun 23, 2026
Reiterated: Buy
Price Target: $20
Current: $13.74
Upside: +45.56%
Zevra Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $26
Current: $12.77
Upside: +103.60%
Traws Pharma
Jun 18, 2026
Downgraded: Hold
Price Target: $8 → $1
Current: $0.671
Upside: +49.03%
Heron Therapeutics
Jun 8, 2026
Maintained: Buy
Price Target: $2
Current: $0.4707
Upside: +324.90%
Jun 5, 2026
Initiated Coverage: Buy
Price Target: $4 → $3
Current: $1.33
Upside: +126.42%
Jun 1, 2026
Reiterated: Buy
Price Target: $10
Current: $4.03
Upside: +148.14%
Jun 1, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $0.8621
Upside: +827.97%
May 26, 2026
Maintained: Buy
Price Target: $8
Current: $1.19
Upside: +575.11%
May 26, 2026
Reiterated: Buy
Price Target: $18
Current: $5.00
Upside: +260.00%
May 26, 2026
Maintained: Buy
Price Target: $29
Current: $7.82
Upside: +270.84%
May 20, 2026
Reiterated: Buy
Price Target: $10
Current: $1.59
Upside: +528.93%
May 15, 2026
Reiterated: Buy
Price Target: $13
Current: $8.42
Upside: +54.39%
May 15, 2026
Reiterated: Buy
Price Target: $60
Current: $26.99
Upside: +122.30%
May 14, 2026
Reiterated: Buy
Price Target: $13
Current: $5.37
Upside: +142.09%
May 14, 2026
Reiterated: Buy
Price Target: $15.43
Current: $9.27
Upside: +66.43%
May 14, 2026
Reiterated: Buy
Price Target: $13
Current: $7.16
Upside: +81.56%
May 8, 2026
Reiterated: Buy
Price Target: $60
Current: $36.08
Upside: +66.30%
May 8, 2026
Reiterated: Buy
Price Target: $10
Current: $8.80
Upside: +13.64%
May 8, 2026
Reiterated: Buy
Price Target: $21
Current: $19.07
Upside: +10.12%
May 1, 2026
Reiterated: Buy
Price Target: $48
Current: $40.54
Upside: +18.40%
Mar 4, 2025
Reiterated: Buy
Price Target: $8 → $200
Current: $2.80
Upside: n/a
Nov 14, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $6.13
Upside: n/a
Aug 22, 2024
Initiated Coverage: Buy
Price Target: $23 → $16
Current: $7.63
Upside: n/a
May 3, 2024
Maintained: Buy
Price Target: $3 → $4
Current: $3.13
Upside: n/a
May 12, 2023
Maintained: Buy
Price Target: $20 → $10
Current: $0.95
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Mar 13, 2023
Maintained: Hold
Price Target: $37 → $33
Current: $0.595
Upside: n/a
Feb 9, 2023
Maintained: Buy
Price Target: $22 → $15
Current: $2.38
Upside: n/a
Feb 3, 2023
Reiterated: Buy
Price Target: $48
Current: $271.82
Upside: n/a
Nov 22, 2022
Maintained: Buy
Price Target: $22 → $40
Current: $0.705
Upside: n/a
Nov 2, 2022
Initiated Coverage: Buy
Price Target: $5
Current: $0.001
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $5 → $50
Current: $0.0111
Upside: n/a
Jan 27, 2022
Upgraded: Buy
Price Target: $22 → $32
Current: $52.72
Upside: n/a
Nov 4, 2021
Reiterated: Buy
Price Target: $23 → $25
Current: $39.85
Upside: n/a
Oct 6, 2021
Maintained: Buy
Price Target: $210
Current: $247.53
Upside: n/a
Aug 9, 2021
Maintained: Buy
Price Target: $6 → $8
Current: $0.000001
Upside: n/a
Jun 30, 2021
Initiated Coverage: Buy
Price Target: $45
Current: $25.00
Upside: n/a
May 6, 2021
Maintained: Buy
Price Target: $18 → $12
Current: $9.60
Upside: n/a
Dec 15, 2020
Reiterated: Buy
Price Target: $25 → $33
Current: $17.38
Upside: n/a
Sep 12, 2016
Reiterated: Buy
Price Target: $34 → $30
Current: $33.31
Upside: n/a